13623-85-3 Usage
Uses
Used in Pharmaceutical Industry:
5,6,7,8-TETRAHYDRO-[1,7]NAPHTHYRIDINE is used as a key intermediate in the synthesis of drug molecules for its potential biological activity. It is particularly valuable for the development of compounds with anti-inflammatory and anticancer properties, given its demonstrated potential in these areas.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 5,6,7,8-TETRAHYDRO-[1,7]NAPHTHYRIDINE is used as a structural component in the design of new pharmaceuticals, leveraging its potential to contribute to the desired therapeutic effects of these compounds.
Used in Antimicrobial and Antiviral Agents Development:
5,6,7,8-TETRAHYDRO-[1,7]NAPHTHYRIDINE is used as a chemical building block in the development of antimicrobial and antiviral agents, due to the promising results observed in naphthyridine derivatives for these applications.
Used in Research and Development:
In research and development settings, 5,6,7,8-TETRAHYDRO-[1,7]NAPHTHYRIDINE is used as a starting material for exploring new chemical reactions and syntheses, further expanding its utility in the creation of novel bioactive compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 13623-85-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,6,2 and 3 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 13623-85:
(7*1)+(6*3)+(5*6)+(4*2)+(3*3)+(2*8)+(1*5)=93
93 % 10 = 3
So 13623-85-3 is a valid CAS Registry Number.
InChI:InChI=1/C8H10N2/c1-2-7-3-5-9-6-8(7)10-4-1/h1-2,4,9H,3,5-6H2
13623-85-3Relevant academic research and scientific papers
PRMT5 INHIBITORS AND USES THEREOF
-
Paragraph 00765; 00766, (2016/04/20)
Described herein are compounds of Formula (A), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof:wherein Y1 is of formula (?) or formula (y):Ring Y is a 5- to 6-membered heteroaryl ring; and V4, V5, Rx, x, y, and n are as defined herein. Compounds of the present invention are useful for inhibiting PRMT5 activity. Methods of using the compounds for treating PRMT5-mediated disorders are also described.
